238 related articles for article (PubMed ID: 24595352)
21. CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance.
Brown JM; Betters JL; Lord C; Ma Y; Han X; Yang K; Alger HM; Melchior J; Sawyer J; Shah R; Wilson MD; Liu X; Graham MJ; Lee R; Crooke R; Shulman GI; Xue B; Shi H; Yu L
J Lipid Res; 2010 Nov; 51(11):3306-15. PubMed ID: 20802159
[TBL] [Abstract][Full Text] [Related]
22. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
23. Monoacylglycerol O-acyltransferase 1 lowers adipocyte differentiation capacity in vitro but does not affect adiposity in mice.
Singer JM; Shew TM; Ferguson D; Renkemeyer MK; Pietka TA; Hall AM; Finck BN; Lutkewitte AJ
Obesity (Silver Spring); 2022 Nov; 30(11):2122-2133. PubMed ID: 36321276
[TBL] [Abstract][Full Text] [Related]
24. Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice.
Bijl N; Sokolović M; Vrins C; Langeveld M; Moerland PD; Ottenhoff R; van Roomen CP; Claessen N; Boot RG; Aten J; Groen AK; Aerts JM; van Eijk M
Hepatology; 2009 Nov; 50(5):1431-41. PubMed ID: 19731235
[TBL] [Abstract][Full Text] [Related]
25. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
26. Hepatic monoacylglycerol acyltransferase activity in HA1 and HA7 hepatoma/hepatocyte hybrid cells: regulation by insulin and dexamethasone and by cell density.
Coleman RA
Biochim Biophys Acta; 1993 Jan; 1165(3):306-13. PubMed ID: 8418888
[TBL] [Abstract][Full Text] [Related]
27. Hepatic ERK activity plays a role in energy metabolism.
Jiao P; Feng B; Li Y; He Q; Xu H
Mol Cell Endocrinol; 2013 Aug; 375(1-2):157-66. PubMed ID: 23732116
[TBL] [Abstract][Full Text] [Related]
28. Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance.
Choi CS; Savage DB; Kulkarni A; Yu XX; Liu ZX; Morino K; Kim S; Distefano A; Samuel VT; Neschen S; Zhang D; Wang A; Zhang XM; Kahn M; Cline GW; Pandey SK; Geisler JG; Bhanot S; Monia BP; Shulman GI
J Biol Chem; 2007 Aug; 282(31):22678-88. PubMed ID: 17526931
[TBL] [Abstract][Full Text] [Related]
29. Reversion of steatosis by SREBP-1c antisense oligonucleotide did not improve hepatic insulin action in diet-induced obesity mice.
Vitto MF; Luz G; Luciano TF; Marques SO; Souza DR; Pinho RA; Lira FS; Cintra DE; De Souza CT
Horm Metab Res; 2012 Nov; 44(12):885-90. PubMed ID: 22932913
[TBL] [Abstract][Full Text] [Related]
30. Increased hepatic insulin action in diet-induced obese mice following inhibition of glucosylceramide synthase.
Yew NS; Zhao H; Hong EG; Wu IH; Przybylska M; Siegel C; Shayman JA; Arbeeny CM; Kim JK; Jiang C; Cheng SH
PLoS One; 2010 Jun; 5(6):e11239. PubMed ID: 20574539
[TBL] [Abstract][Full Text] [Related]
31. Effects of octreotide on hepatic glycogenesis in rats with high fat diet‑induced obesity.
Wang XX; Ye T; Li M; Li X; Qiang O; Tang CW; Liu R
Mol Med Rep; 2017 Jul; 16(1):109-118. PubMed ID: 28534956
[TBL] [Abstract][Full Text] [Related]
32. Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents.
Vatner DF; Goedeke L; Camporez JG; Lyu K; Nasiri AR; Zhang D; Bhanot S; Murray SF; Still CD; Gerhard GS; Shulman GI; Samuel VT
Diabetologia; 2018 Jun; 61(6):1435-1446. PubMed ID: 29497783
[TBL] [Abstract][Full Text] [Related]
33. Hepatic nitric oxide synthase 1 adaptor protein regulates glucose homeostasis and hepatic insulin sensitivity in obese mice depending on its PDZ binding domain.
Mu K; Sun Y; Zhao Y; Zhao T; Li Q; Zhang M; Li H; Zhang R; Hu C; Wang C; Jia W
EBioMedicine; 2019 Sep; 47():352-364. PubMed ID: 31473185
[TBL] [Abstract][Full Text] [Related]
34. Reduced adiposity and improved insulin sensitivity in obese mice with antisense suppression of 4E-BP2 expression.
Yu XX; Pandey SK; Booten SL; Murray SF; Monia BP; Bhanot S
Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E530-9. PubMed ID: 18198353
[TBL] [Abstract][Full Text] [Related]
35. Fenofibrate insulates diacylglycerol in lipid droplet/ER and preserves insulin signaling transduction in the liver of high fat fed mice.
Chan SM; Zeng XY; Sun RQ; Jo E; Zhou X; Wang H; Li S; Xu A; Watt MJ; Ye JM
Biochim Biophys Acta; 2015 Jul; 1852(7):1511-9. PubMed ID: 25906681
[TBL] [Abstract][Full Text] [Related]
36. Reduction of low molecular weight protein-tyrosine phosphatase expression improves hyperglycemia and insulin sensitivity in obese mice.
Pandey SK; Yu XX; Watts LM; Michael MD; Sloop KW; Rivard AR; Leedom TA; Manchem VP; Samadzadeh L; McKay RA; Monia BP; Bhanot S
J Biol Chem; 2007 May; 282(19):14291-9. PubMed ID: 17353188
[TBL] [Abstract][Full Text] [Related]
37. Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis.
Monsénégo J; Mansouri A; Akkaoui M; Lenoir V; Esnous C; Fauveau V; Tavernier V; Girard J; Prip-Buus C
J Hepatol; 2012 Mar; 56(3):632-9. PubMed ID: 22037024
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of MGAT2 modulates fat-induced gut peptide release and fat intake in normal mice and ameliorates obesity and diabetes in ob/ob mice fed on a high-fat diet.
Mochida T; Take K; Maki T; Nakakariya M; Adachi R; Sato K; Kitazaki T; Takekawa S
FEBS Open Bio; 2020 Mar; 10(3):316-326. PubMed ID: 31837122
[TBL] [Abstract][Full Text] [Related]
39. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice.
De Souza CT; Frederico MJ; da Luz G; Cintra DE; Ropelle ER; Pauli JR; Velloso LA
J Physiol; 2010 Jun; 588(Pt 12):2239-53. PubMed ID: 20421289
[TBL] [Abstract][Full Text] [Related]
40. Arctic berry extracts target the gut-liver axis to alleviate metabolic endotoxaemia, insulin resistance and hepatic steatosis in diet-induced obese mice.
Anhê FF; Varin TV; Le Barz M; Pilon G; Dudonné S; Trottier J; St-Pierre P; Harris CS; Lucas M; Lemire M; Dewailly É; Barbier O; Desjardins Y; Roy D; Marette A
Diabetologia; 2018 Apr; 61(4):919-931. PubMed ID: 29270816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
